iXCells Biotechnologies Launches iPSCore^™ Platform for Generating Highly Characterized iPSC-derived Human Cell Models

iXCells Biotechnologies announced the launch of its modular iPSCore^™ platform. iPSCore^™ is a system where tools, experiences, and expertise are structured together to design, develop and build iPSC-derived cell products from ethically sourced biospecimens, and cell fractions or cells derived from healthy or patient donors.